Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02024542 · ClinicalTrials.gov registry record
Metabolic Responses to Bariatric Surgery
A clinical trial of Morbid Obesity, sponsored by University of California, Davis.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT02024542: Recruiting study of Morbid Obesity, sponsored by University of California, Davis.
NCT02024542 is a study of Morbid Obesity that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 500 participants, above the 101-participant average among 24 other Morbid Obesity trials with a reported enrollment target (395% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02024542, a study of Morbid Obesity, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Research the genetic and biomechanical markers of human adipose tissue on patients with morbid obesity. Additional tissue/fluid collection is also gathered during the time of surgery.
Primary Outcome
During the research tissue samples were compared between healthy obese patients (no diabetes, controlled HTN, no dyslipidemia) with tissue samples collected on non-healthy obese patients (type II diabetes) and using fat collected from mice as a control.
Conditions Studied
Interventions
- OTHER Surgery
Study Locations (1)
California
- University of California Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2011-02 |
| Est. Completion | 2035-04 |
What NCT02024542 shows while recruiting
NCT02024542 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 101-participant average among 24 other Morbid Obesity trials with a reported enrollment target (395% higher).
The record links to 1 condition, with Morbid Obesity appearing as the primary indexed condition, and to 1 intervention - of which Surgery is the first listed.
NCT02024542 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02024542 about?
NCT02024542 is a clinical study titled "Metabolic Responses to Bariatric Surgery". Research the genetic and biomechanical markers of human adipose tissue on patients with morbid obesity. Additional tissue/fluid collection is also gathered during the time of surgery.
What is the current status of trial NCT02024542?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2011-02. Estimated completion is 2035-04.
What conditions does trial NCT02024542 study?
This clinical trial studies the following conditions: Morbid Obesity.
What interventions are being tested in trial NCT02024542?
The interventions under investigation include: Surgery (OTHER).
Who is sponsoring clinical trial NCT02024542?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02024542 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Morbid Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02024542's enrollment target sits among peer trials
500 1st of 24 higher than 24 of 24 other Morbid Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Morbid Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Induction of Labor in Morbidly Obese Patients
RECRUITING · Early Phase 1
-
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
RECRUITING
-
Impact GLP-1 Agonists Following Bariatric
RECRUITING · Phase 4
-
Gut Microbiota in Metabolic Surgery
RECRUITING
-
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
RECRUITING · NA
-
Appetite Suppression / Hormone Study Control Group
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia